• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  03/04/2020
Trade Name:  Cleocin Phosphate
Generic Name or Proper Name (*):  clindamycin injection; clindamycin injection in dextrose
Indications Studied:  Postmarketing study
Label Changes Summary:  *The following statement was added to Dosage and Administration section: Clindamycin should be dosed on total body weight regardless of body weight. *Obese Pediatric Patients Aged 2 to Less than 18 Years and Obese Adults Aged 18 to 20 Years: An analysis of pharmacokinetic data in obese pediatric patients aged 2 to less than 18 years and obese adults aged 18 to 20 years demonstrated that clindamycin clearance and volume of distribution, normalized by total body weight, are comparable regardless of obesity. *Off-patent Written Request.
Sponsor:  Pfizer, Inc.
Therapeutic Category:  Antibiotic